Screener
Bristol-Myers Squibb BMY Switzerland — Withholding Tax
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits.
The source filing: Bristol-Myers Squibb’s 10-K, filed February 11, 2026.
- Filed
- Feb 10, 2026, 7:00 PM EST
- Fiscal year
- FY2025
- Accession
- 0000014272-26-000004
| Dollars in millions | % of Earnings Before Income Taxes / 2025 |
|---|---|
| Statutory tax rate difference between Switzerland and the U.S. | (565)% |
| Canton | 284% |
| Pillar Two | 24% |
| Withholding Tax | 87% |
| Other | (11)% |
| Ireland | |
| Statutory tax rate difference between Ireland and the U.S. | (390)% |
| Pillar Two | 37% |
Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
FAQ
- What is Bristol-Myers Squibb's switzerland — withholding tax?
- Bristol-Myers Squibb (BMY) reported switzerland — withholding tax of $0 in Q4 2025.
- What does switzerland — withholding tax mean?
- This metric represents the tax withheld on cross-border payments, such as dividends, royalties, or interest, originating from or flowing to Swiss entities. It serves as an indicator of the tax friction associated with the company's international capital and cash flow management. High levels may suggest inefficiencies in the company's intercompany financing or profit repatriation strategies.
Ask your AI about Bristol-Myers Squibb's switzerland — withholding tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude